The long term survivors

British Medical Bulletin

Volumn 52, Issue 4, 1996, Pages 898-923

  Hawkins, M M ^a   Stevens, M C G ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; IFOSFAMIDE; RAZOXANE;

BODY HEIGHT; BONE DISEASE; CANCER RECURRENCE; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; CHILD GROWTH; CHILDHOOD CANCER; FERTILITY; FOLLOW UP; HUMAN; LUNG TOXICITY; MORBIDITY; MORTALITY; NEPHROTOXICITY; NEUROTOXICITY; PATIENT EDUCATION; PATIENT MONITORING; PREGNANCY; PRIORITY JOURNAL; PUBERTY; REVIEW; RISK BENEFIT ANALYSIS; SOCIAL PSYCHOLOGY; THYROID DISEASE; UNITED KINGDOM;

EID: 0030444917     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011590     Document Type: Review

References (68)

1. Robertson CM, Hawkins MM, Kingston JE. Late deaths and survival after childhood cancer: implications for cure. BMJ 1994; 309: 162-6
2. Stiller CA. Population based survival rates for childhood cancer in Britain, 1980-91. BMJ 1994; 309: 1612-6
3. Hawkins MM, Draper GJ, Kingston JE. Incidence of second primary tumours among childhood cancer survivors. Br J Cancer 1987; 56, 339-47
4. Olsen JH, Garwicz S, Hertz H et al. Second malignant neoplasms after cancer in childhood or adolescence. BMJ 1993; 307: 1030-6
5. Tucker MA, Meadows AT, Boice JD, Hoover RN, Fraumeni JF. Cancer risk following treatment of childhood cancer. In: Boice JD, Fraumeni JF, eds. Radiation Carcinogenesis: Epidemiology and Biological Significance. New York: Raven, 1984; 211-24
6. Tucker MA, D'Angio GJ, Boice JD et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 1987; 317: 588-93
7. Hawkins MM, Kinnier Wilson LM, Burton HS et al. Radiotherapy, alkylating agents and the risk of bone cancer after childhood cancer. J Natl Cancer Inst 1996; 88: 270-8
8. Tucker MA, Meadows AT, Boice JD et al. Leukaemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst 1987; 78: 459-64
9. Hawkins MM, Kinnier Wilson LM, Stovall MA et al. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. BMJ 1992; 304: 951-8
10. Pui CH, Ribeiro RC, Hancock ML et al. Acute myeloid leukaemia in children treated with epipodophyllotoxins for acute lymphoblastic leukaemia. N Engl J Med 1991; 325: 1682-7
11. Pedersen-Bjergaard J. Acute promyelocytic leukaemia with t(15;17) following inhibition of DNA topoisomerase II. Ann Oncol 1995; 6: 751-3
12. Ron E, Lubin JH, Shore RE et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995; 141: 259-77
13. Neglia JP, Meadow AT, Robinson LL et al. Second neoplasms after acute lymphoblastic leukaemia in childhood. N Engl J Med 1991; 325: 1330-6
14. Bhatia S, Robinson LL, Oberlin O et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996; 334: 745-51
15. Breslow NE, Takashima JR, Whitton JA, Moksness J, D'Angio GJ, Green DM. Second malignant neoplasms following treatment for Wilms' tumour: a report from the National Wilms' Tumour Study Group. J Clin Oncol 1995; 13: 1851-9
16. Rappaport R, Brauner R. Growth and endocrine disorders secondary to cranial irradiation. Pediatr Res 1989; 25: 561-7
17. Shalet SM, Clayton PE. Factors influencing the development of irradiation induced growth hormone deficiency. Horm Res 1990; 33: 99
18. Sanders JE, Buckner CD, Sullivan KM et al. Growth and development in children after bone marrow transplant. Horm Res 1988; 30: 92-7
19. Clayton PE, Shalet SM, Morris Jones PH et al. Growth in children treated for acute lymphoblastic leukaemia. Lancet 1988; i: 460-2
20. Constine LS, Donaldson SS, McDougall IR. Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Cancer 1984; 53: 878-83
21. Rogers PC, Fryer CJ, Hussein S. Radiation dose to the thyroid in the treatment of acute lymphoblastic leukaemia. Med Pediatr Oncol 1982; 10: 385-8
22. Hawkins MM, Kingston J. Malignant thyroid tumours following childhood cancer. Lancet 1988; ii: 455
23. Shalet SM. Disorders of gonadal function due to radiation and cytotoxic chemotherapy in children. Adv Intern Med Pediatr 1989; 58: 1-21
24. Leiper AD et al. Precocious and premature puberty associated with treatment of acute lymphoblastic leukaemia. Arch Dis Child 1987; 62: 1107-12
25. Byrne J, Mulvihill JJ, Myers MH et al. Effects of treatment on fertility in long term survivors of childhood or adolescent cancer. N Engl J Med 1987; 317: 1315-21
26. Byrne J, Fears TR, Gail MH et al. Early menopause in long term survivors of cancer during adolescence. Am J Obstet Gynecol 1992; 166: 788-93
27. Hawkins MM, Smith RA, Curtis LJ. Childhood cancer survivors and their offspring studied through a postal survey of general practitioners: preliminary results. J R Coll Gen Pract 1988; 38: 102-5
28. Hawkins MM, Smith RA. Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer 1989; 43: 399-402
29. Li FP, Gimbrere K, Gelber RD et al. Outcome of pregnancy in survivors of Wilms' tumour. JAMA 1987; 257: 216-19
30. Smith RA, Hawkins MM. Pregnancies after childhood cancer. Br J Obstet Gynaecol 1989; 96: 378-80
31. Hawkins MM. Pregnancy outcome and offspring after childhood cancer. BMJ 1994; 309, 1034
32. Hawkins MM, Draper GJ, Winter DL. Cancer in the offspring of survivors of childhood leukaemia and non-Hodgkin's lymphoma. Br J Cancer 1995; 71: 1335-39
33. Hawkins MM, Winter DL, Burton HS, Potok MHN. Heritability of Wilms' tumour. J Natl Cancer Inst 1995; 87: 1323-4
34. Hawkins MM. Is there evidence of a therapy-related increase in germ cell mutation among childhood cancer survivors? J Natl Cancer Inst 1991 83: 1643-50
35. Steinherz LJ, Steinherz PG, Tan CTC, Heller G, Murphy L. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 1991; 226: 1672-7
36. Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukaemia in childhood. N Engl J Med 1991; 324: 808-15
37. Lipshultz SE, Lipsitz SR, Mone SM et al. Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 1995; 332: 1738-43
38. Wexler LH, Andrich MP, Venzon D et al. Randomized trial of the cardioprotective agent ICRF-187 in paediatric sarcoma patients treated with doxorubicin. J Clin Oncol 1996; 14: 362-72
39. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in childhood and adolescents. J Clin Oncol 1993; 11: 1208-15
40. Miller RW, Fusner JE, Fink RJ et al. Pulmonary function abnormalities in long term survivors of childhood cancer. Med Pediatr Oncol 1986; 14: 202-7
41. Jakacki RI, Schramm, Donahue B et al. Restrictive lung disease following treatment for malignant brain tumours: a potential late effect of craniospinal irradiation. J Clin Oncol 1995; 13: 1478-85
42. Eigen H, Wyszomierski D. Bleomycin lung injury in children. Pathophysiology and guidelines for management. Am J Pediatr Hematol Oncol 1985; 7: 71-8
43. O'Driscoll BR, Hasleton PS, Taylor PM et al. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med 1990; 323: 378-82
44. Shaw NA, Tweedale PM, Eden OB. Pulmonary function in childhood leukemia survivors. Med Pediatr Oncol 1989; 17: 149-54
45. Raney RB, Heyn R, Cassady R et al. Late effects of cancer therapy on the genitourinary tract in children. In: Schwartz CL, Hobbie WL, Constine LS, Ruccione KS, eds. Survivors of Childhood Cancer: Assessment and Management. St Louis: Mosby, 1994; 245-62
46. Skinner R, Pearson ADJ, Coulthard MG et al. Assessment of chemotherapy associated nephrotoxicity in children with cancer. Cancer Chemother Pharmacol 1991; 28: 81-92
47. Skinner R, Sharkey IM, Pearson ADJ. Ifosfamide, mesna and nephrotoxicity in children. J Clin Oncol 1993; 11: 173-90
48. Jayalakshmamma B, Pinkel D. Urinary bladder toxicity following pelvic irradiation and simultaneous cyclophosphamide therapy. Cancer 1976; 38: 701-7
49. Flamant F, Gerbaulet A, Nihoul-Fekete C et al. Long term sequelae of conservative treatment by surgery, brachytherapy and chemotherapy for vulval and vaginal rhabdomyosarcoma in children. J Clin Oncol 1990; 8: 1847-53
50. Fletcher JM, Copeland DR. Neurobehavioural effects of central nervous system prophylactic treatment of cancer in children. J Clin Exp Neuropsychol 1988; 10: 495-538
51. Brouwers P, Poplack D. Memory and learning sequelae in long term survivors of acute lymphoblastic leukaemia: Association with attention defects. Am J Pediatr Hematol Oncol 1990; 12: 174-81
52. Christie D, Leiper AD, Chessells JM et al. Intellectual performance after pre symptomatic cranial radiotherapy for leukaemia: effects of age and sex. Arch Dis Child 1995; 73: 136-40
53. Mostow EN, Byrne J, Connelly RR. Quality of life in long term survivors of central nervous system tumours of childhood and adolescence. J Clin Oncol 1991; 9: 592-9
54. Pizzo P, Poplack DG, Bleyer WA. Neurotoxicities of current leukemia therapy. Am J Pediatr Hematol Oncol 1979; 1: 127-38
55. Donaldson SS, Jundt S, Ricour C et al. Radiation enteritis in children. A retrospective review, clinicopathologic correlation and dietary management. Cancer 1975; 35: 1167-78
56. Barnard JA, Marshall GS, Neblett WW et al. Noncirrhotic portal fibrosis after Wilms' tumour therapy. Gastroenterology 1986; 90: 1054-6
57. Eifel PJ, Donaldson SS, Thomas PRM. Response of growing bone to irradiation: a proposed late effects scoring system. Int J Radiat Oncol Biol Phys 1995; 31: 1301-7
58. Silber JH, Littman PS, Meadows AT. Stature loss following skeletal irradiation for childhood cancer. J Clin Oncol 1990; 8: 304-12
59. Rosenfield NS, Haller JO, Berdon WE et al. Failure of development of the growing breast after radiotherapy. Pediatr Radiol 1989; 19: 124-7
60. Nylander G, Petterson F, Swedenborg J. Localised arterial occlusions in patients treated with pelvic field radiation for cancer. Cancer 1978; 41: 2158-61
61. Mauch P, Constine L, Greenberger J et al. Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. Int J Radiat Oncol Biol Phys 1995; 31: 1319-39
62. Deeg HJ, Fluornoy N, Sullivan KM et al. Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. Int J Radiat Oncol Biol Phys 1984; 10: 957-64
63. Heyn R, Ragab A, Raney RB et al. Late effects of therapy in orbital RMS in children: a report of the Intergroup Rhabdomyosarcoma Study. Cancer 1986; 57, 1738-43
64. Eiser C, Haverraans T. Long term social adjustment after treatment for childhood cancer. Arch Dis Child 1994; 70: 66-70
65. Lansky SB, List MA, Ritter-Steer C. Psychosocial consequences of cure. Cancer 1986; 58: 629-33
66. Ruccoine KS. Issues in survivorship. In: Schwartz CL, Hobbie WL, Constine LS, Ruccoine KS, eds. Survivors of Childhood Cancer: Assessment and Management. St Louis: Mosby, 1994; 329-37
67. Jenney MEM, Kane RL, Lurie N. Developing a measure of health outcomes in survivors of childhood cancer: a review of the issues. Med Pediatr Oncol 1995; 24: 145-53
68. Pinkerton CR. Avoiding chemotherapy related late effects in children with curable tumours. Arch Dis Child 1992; 67: 116-9